Model and cell membrane partitioning of perfluorooctanesulfonate is independent of the lipid chain length

Colloids and Surfaces B: Biointerfaces

Volumn 76, Issue 1, 2010, Pages 128-136

  Xie, Wei ^a   Ludewig, Gabriele ^a   Wang, Kai ^a   Lehmler, Hans Joachim ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Alveolar macrophages; Cooperativity; Differential scanning calorimetry; DPH; Fluorescence anisotropy; HL 60 human leukemia cells; Phosphatidylcholines; TMA DPH

Indexed keywords

ALVEOLAR MACROPHAGES; COOPERATIVITY; DPH FLUORESCENCE; HUMAN LEUKEMIA CELLS; PHOSPHATIDYL CHOLINE;

ANIMALS; ANISOTROPY; CALORIMETERS; CELL MEMBRANES; CHAIN LENGTH; CRYSTALLINE MATERIALS; CYTOLOGY; DIFFERENTIAL SCANNING CALORIMETRY; FLUIDITY; FLUIDIZATION; FLUORESCENCE; GELS; LIQUIDS; MACROPHAGES; MEMBRANES; SCANNING; THERMOANALYSIS;

PHASE TRANSITIONS;

DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLCHOLINE; LIPID; PERFLUOROOCTANESULFONIC ACID;

ANIMAL CELL; ANISOTROPY; ARTICLE; CELL MEMBRANE FLUIDITY; CELL STRAIN HL 60; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; FLUIDIZATION; FLUORESCENCE ANALYSIS; GEL; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIQUID; LUNG ALVEOLUS MACROPHAGE; MEMBRANE MODEL; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; RAT; TRANSITION TEMPERATURE;

ALKANESULFONIC ACIDS; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE, TUMOR; CELL MEMBRANE; FEMALE; FLUOROCARBONS; HUMANS; LIPID BILAYERS; MODELS, BIOLOGICAL; PHOSPHATIDYLCHOLINES; RATS; RATS, SPRAGUE-DAWLEY; SURFACE-ACTIVE AGENTS;

ANIMALIA; RATTUS;

EID: 74049113323     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2009.10.025     Document Type: Article

References (54)

1. Kissa E. Fluorinated Surfactants and Repellents (Surfactant Science Series) vol. 97 (2001), Marcel Dekker, New York
2. Lehμλer H.-J. Synthesis of environmentally relevant fluorinated surfactants-a review. Chemosphere 58 (2005) 1471-1496
3. Paul A.G., Jones K.C., and Sweetman A.J. A first global production, emission, and environmental inventory for perfluorooctane sulfonate. Environ. Sci. Technol. 43 (2009) 386-392
4. Tomy G.T., Tittlemier S.A., Palace V.P., Budakowski W.R., Braekevelt E., Brinkworth L., and Friesen K. Biotransformation of N-ethyl perfluorooctanesulfonamide by rainbow trout (Onchorhynchus mykiss) liver microsomes. Environ. Sci. Technol. 38 (2004) 758-762
5. Xu L., Krenitsky D.M., Seacat A.M., Butenhoff J.L., Tephly T.R., and Anders M.W. N-glucuronidation of perfluorooctanesulfonamide by human, rat, dog, and monkey liver microsomes and by expressed rat and human UDP-glucuronosyltransferases. Drug Metab. Dispos. 34 (2006) 1406-1410
6. Xu L., Krenitsky D.M., Seacat A.M., Butenhoff J.L., and Anders M.W. Biotransformation of N-ethyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450. Chem. Res. Toxicol. 17 (2004) 767-775
7. Xie W., Wu Q., Kania-Korwel I., Tharappel J.C., Telu S., Coleman M.C., Glauert H.P., Kannan K., Mariappan S.V.S., Spitz D.R., Weydert J., and Lehmler H.-J. Subacute exposure to N-ethyl perfluorooctanesulfonamidoethanol results in the formation of perfluorooctanesulfonate and alters superoxide dismutase activity in female rats. Arch. Toxicol. 83 (2009) 909-924
8. Organization for Economic Cooperation and Development, Environment Directorate. Hazard assessment of perfluorooctane sulfonate (PFOS) and its salts. Report ENV/JM/RD(2002)17/FINAL, Paris, 2002.
9. Andersen M.E., Clewell H.J., Tan Y.-M., Butenhoff J.L., and Olsen G.W. Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys-probing the determinants of long plasma half-lives. Toxicology 227 (2006) 156-164
10. Lau C., Butenhoff J.L., and Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 198 (2004) 231-241
11. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., and Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 99 (2007) 366-394
12. Washino N., Saijo Y., Sasaki S., Kato S., Ban S., Konishi K., Ito R., Nakata A., Iwasaki Y., Saito K., Nakazawa H., and Kishi R. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ. Health Perspect. 117 (2009) 660-667
13. Abbott B.D., Wolf C.J., Das K.P., Zehr R.D., Schmid J.E., Lindstrom A.B., Strynar M.J., and Lau C. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPARalpha) in the mouse. Reprod. Toxicol. 27 (2009) 258-265
14. Starkov A.A., and Wallace K.B. Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol. Sci. 66 (2002) 244-252
15. Hu W., Jones P.D., Upham B.L., Trosko J.E., Lau C., and Giesy J.P. Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo. Toxicol. Sci. 68 (2002) 429-436
16. Luebker D.J., Hansen K.J., Bass N.M., Butenhoff J.L., and Seacat A.M. Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology 176 (2002) 175-185
17. Berthiaume J., and Wallace K.B. Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis. Toxicol. Lett. 129 (2002) 23-32
18. Sohlenius A.K., Eriksson A.M., Hogstrom C., Kimland M., and DePierre J.W. Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver. Pharmacol. Toxicol. 72 (1993) 90-93
19. Abbott B.D., Wolf C.J., Schmid J.E., Das K.P., Zehr R.D., Helfant L., Nakayama S., Lindstrom A.B., Strynar M.J., and Lau C. Perfluorooctanoic acid-induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator-activated receptor-alpha. Toxicol. Sci. 98 (2007) 571-581
20. Lehmler H.-J., Xie W., Bothun G.D., Bummer P.M., and Knutson B.L. Mixing of perfluorooctanesulfonic acid (PFOS) potassium salt with dipalmitoyl phosphatidylcholine (DPPC). Colloids Surf. B 51 (2006) 25-29
21. Luebker D.J., York R.G., Hansen K.J., Moore J.A., and Butenhoff J.L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharmacokinetic parameters. Toxicology 215 (2005) 149-169
22. Xie W., Kania-Korwel I., Bummer P.M., and Lehmler H.-J. Effect of potassium perfluorooctanesulfonate, perfluorooctanoate and octanesulfonate on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayers. Biochim. Biophys. Acta 1768 (2007) 1299-1308
23. Matyszewska D., Tappura K., Oradd G., and Bilewicz R. Influence of perfluorinated compounds on the properties of model lipid membranes. J. Phys. Chem. B 111 (2007) 9908-9918
24. Hu W., Jones P.D., DeCoen W., King L., Fraker P., Newsted J., and Giesy J.P. Alterations in cell membrane properties caused by perfluorinated compounds. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 135C (2003) 77-88
25. Gordon S.C., Schurch S., Amrein M., and Schoel M. Effects of perfluorinated acids on pulmonary surfactant properties in vitro. Toxicologist 96 (2007) 91
26. Grasty R.C., Bjork J.A., Wallace K.B., Lau C.S., and Rogers J.M. Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res. Part B: Dev. Reprod. Toxicol. 74 (2005) 405-416
27. Vyas S.M., Kania-Korwel I., and Lehmler H.-J. Differences in the isomer composition of perfluoroctanesulfonyl (PFOS) derivatives. J. Environ. Sci. Health A 42 (2007) 249-255
28. Arora M., Bummer P.M., and Lehmler H.-J. Interaction of a partially fluorinated heptadecanoic acid with diacyl phosphatidylcholines of varying chain length. Langmuir 19 (2003) 8843-8851
29. Lehmler H.-J., and Bummer P.M. Mixing of perfluorinated carboxylic acids with dipalmitoylphosphatidylcholine. Biochim. Biophys. Acta 1664 (2004) 141-149
30. Bernsdorff C., Wolf A., Winter R., and Gratton E. Effect of hydrostatic pressure on water penetration and rotational dynamics in phospholipid-cholesterol bilayers. Biophys. J. 72 (1997) 1264-1277
31. 2 determined by fluorescence anisotropy. Langmuir 21 (2005) 530-536
32. Hashizaki K., Taguchi H., Itoh C., Sakai H., Abe M., Saito Y., and Ogawa N. Effects of poly(ethylene glycol) (PEG) concentration on the permeability of PEG-grafted liposomes. Chem. Pharm. Bull. 53 (2005) 27-31
33. Inoue T., Iwanaga T., Fukushima K., and Shimozawa R. Effect of sodium octanoate and sodium perfluorooctanoate on gel-to-liquid-crystalline phase transition of dipalmitoylphosphatidylcholine vesicle membrane. Chem. Phys. Lipids 46 (1988) 25-30
34. Koynova R., and Caffrey M. Phases and phase transitions of the phosphatidylcholines. Biochim. Biophys. Acta 1376 (1998) 91-145
35. Lehmler H.-J., and Bummer P.M. Mixing behavior of 10-(perfluorohexyl)-decanol and DPPC. Colloids Surf. B 44 (2005) 74-81
36. Koynova R.D., Boyanov A.I., and Tenchov B.G. Gel-state metastability and nature of the azeotropic points in mixtures of saturated phosphatidylcholines and fatty acids. Biochim. Biophys. Acta 903 (1987) 186-196
37. Eliasz A.W., Chapman D., and Ewing D.F. Phospholipid phase transitions. Effects of n-alcohols, n-monocarboxylic acids, phenylalkyl alcohols and quarternary ammonium compounds. Biochim. Biophys. Acta 448 (1976) 220-230
38. Lehmler H.-J., Oyewumi M.O., Jay M., and Bummer P.M. Behavior of partially fluorinated carboxylic acids at the air-water interface. J. Fluorine Chem. 107 (2001) 141-146
39. Lehmler H.-J., and Bummer P.M. Mixing of partially fluorinated carboxylic acids with their hydrocarbon analogs at the air-water interface. J. Colloid Interface Sci. 249 (2002) 381-387
40. Allison D.C., and Ridolpho P. Use of a trypan blue assay to measure the deoxyribonucleic acid content and radioactive labeling of viable cells. J. Histochem. Cytochem. 28 (1980) 700-703
41. Lehmler H.-J., Xu L., Vyas S.M., Ojogun V.A., Knutson B.L., and Ludewig G. Synthesis, physicochemical properties and in vitro cytotoxicity of nicotinic acid ester prodrugs intended for pulmonary delivery using perfluorooctyl bromide as vehicle. Int. J. Pharm. 353 (2008) 35-44
42. Petkovic M., Vocks A., Mueller M., Schiller J., and Arnhold J. Comparison of different procedures for the lipid extraction from HL-60 cells: a MALDI-TOF mass spectrometric study. Z. Naturforsch. C: J. Biosci. 60 (2005) 143-151
43. Chen P.S., Toribara T.Y., and Warner H. Microdetermination of phosphorus. Anal. Chem. 28 (1956) 1756-1758
44. Kuhry J.G., Duportail G., Bronner C., and Laustriat G. Plasma membrane fluidity measurements on whole living cells by fluorescence anisotropy of trimethylammonium diphenylhexatriene. Biochim. Biophys. Acta: Mol. Cell Res. 845 (1985) 60-67
45. Kaiser R.D., and London E. Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth. Biochemistry 37 (1998) 8180-8190
46. Mukerjee P., and Yang A.Y.S. Nonideality of mixing of micelles of fluorocarbon and hydrocarbon surfactants and evidence of partial miscibility from differential conductance data. J. Phys. Chem. 80 (1976) 1388-1390
47. Nakahara H., Nakamura S., Kawasaki H., and Shibata O. Properties of two-component Langmuir monolayer of single chain perfluorinated carboxylic acids with dipalmitoylphosphatidylcholine (DPPC). Colloids Surf. B 41 (2005) 285-298
48. Mukerjee P., and Handa T. Adsorption of fluorocarbon and hydrocarbon surfactants to air-water, hexane-water, and perfluorohexane-water interfaces. Relative affinities and fluorocarbon-hydrocarbon nonideality effects. J. Phys. Chem. 85 (1981) 2298-2303
49. Kamaya H., Kaneshina S., and Ueda I. Partition equilibrium of inhalation anesthetics and alcohols between water and membranes of phospholipids with varying acyl chain-lengths. Biochim. Biophys. Acta 646 (1981) 135-142
50. Jain M.K., and Wu N.M. Effect of small molecules on the dipalmitoyl lecithin liposomal bilayer. III. Phase transition in lipid bilayer. J. Membr. Biol. 34 (1977) 157-201
51. Lohner K. Effects of small organic molecules on phospholipid phase transitions. Chem. Phys. Lipids 57 (1991) 341-362
52. Ellena J.F., Obraztsov V.V., Cumbea V.L., Woods C.M., and Cafiso D.S. Perfluorooctyl bromide has limited membrane solubility and is located at the bilayer center. Locating small molecules in lipid bilayers through paramagnetic enhancements of NMR relaxation. J. Med. Chem. 45 (2002) 5534-5542
53. Inoue T., Miyakawa K., and Shimozawa R. Interaction of surfactants with vesicle membrane of dipalmitoylphosphatidylcholine. Effect on gel-to-liquid-crystalline phase transition of lipid bilayer. Chem. Phys. Lipids 42 (1986) 261-270
54. Ricardo Jr. M.J., Small G.W., Myrvik Q.N., and Kucera L.S. Lipid composition of alveolar macrophage plasma membrane during postnatal development. J. Immunol. 136 (1986) 1054-1060